Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.

Galor, A; Karp, C L; Chhabra, S; Barnes, S; Alfonso, E C

Galor, A; Karp, C L; Chhabra, S; Barnes, S; Alfonso, E C.

Affiliation

Galor A; Bascom Palmer Eye Institute, 900 NW 17 Street, Miami, FL 33136, USA.

Br J Ophthalmol ; 94(5): 551-4, 2010 May.

Article in En | MEDLINE | ID: mdl-19493859

Subject(s)

Antineoplastic Agents/administration & dosage; Carcinoma in Situ/drug therapy; Carcinoma, Squamous Cell/drug therapy; Conjunctival Neoplasms/drug therapy; Interferon-alpha/administration & dosage; Adult; Aged; Aged, 80 and over; Antineoplastic Agents/adverse effects; Dose-Response Relationship, Drug; Female; Humans; Interferon alpha-2; Interferon-alpha/adverse effects; Male; Middle Aged; Neoplasm Recurrence, Local; Ophthalmic Solutions; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma in Situ / Carcinoma, Squamous Cell / Interferon-alpha / Conjunctival Neoplasms / Antineoplastic Agents Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google